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Most humans carry a mixed population of mitochondrial DNA (mtDNA heteroplasmy)
affecting ~1–2% of molecules, but rapid percentage shifts occur over one generation leading
to severe mitochondrial diseases. A decrease in the amount of mtDNA within the developing
female germ line appears to play a role, but other sub-cellular mechanisms have been
implicated. Establishing an in vitro model of early mammalian germ cell development from
embryonic stem cells, here we show that the reduction of mtDNA content is modulated by
oxygen and reaches a nadir immediately before germ cell specification. The observed genetic
bottleneck was accompanied by a decrease in mtDNA replicating foci and the segregation of
heteroplasmy, which were both abolished at higher oxygen levels. Thus, differences in oxygen
tension occurring during early development likely modulate the amount of mtDNA, facil-
itating mtDNA segregation and contributing to tissue-specific mutation loads.
https://doi.org/10.1038/s42003-021-02069-2 OPEN
1 Department of Clinical Neurosciences, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.
2Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0XY, UK. 3 Department of
Mathematics, Imperial College London, London SW7 2AZ, UK. 4Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University,
Kyoto 606-8501, Japan. 5 JST, ERATO, Kyoto University, Kyoto 606-8501, Japan. 6Present address: Department of Medicine, Columbia University Medical
Center, New York, NY, USA. 7These authors contributed equally: Aurora Gomez-Duran, Florian Klimm. ✉email: pfc25@cam.ac.uk









Mammalian cells contain many copies of the circularmitochondrial DNA (mtDNA), which codes for 13proteins required for oxidative metabolism and the
synthesis of adenosine triphosphate (ATP)1. mtDNA is almost
exclusively maternally inherited, and until recently, it was
assumed that in most humans all of mtDNA was identical
(homoplasmic wild-type; WT). However, single-cell and mas-
sively parallel bulk mtDNA sequencing has shown the converse—
that most if not all humans have a mixed population of mtDNA
molecules (heteroplasmy)2. Usually these mutations only affect
the minority of mtDNA molecules (~1–2%), falling well below
the critical threshold (50–85%) typically required to cause a cel-
lular biochemical defect1,2. However, rapid changes in hetero-
plasmy are seen during maternal transmission, explaining why an
unaffected woman carrying a pathogenic mutation can have a
child with a severe mtDNA disease, known to affect ~1 in 8500 of
the population3. In patients with mtDNA diseases, affected cells
and organs have higher levels of heteroplasmy, but it is not clear
how the tissue-specific segregation arises during development2.
Heteroplasmic mtDNA mutations have also been implicated in
the pathogenesis of common late-onset disorders including
neurodegenerative diseases4, and even the ageing process itself5,
so the mechanisms of heteroplasmy segregation have far-reaching
implications.
Rapid shifts in heteroplasmy were first seen in Holstein cows
leading to the mitochondrial bottleneck hypothesis6, where only a
small proportion of the maternal mitochondria contribute to the
next generation. The bottleneck is thought to cause a sampling
effect resulting in different proportions of mutant and WT
molecules in each offspring. Heteroplasmy measurements across
several species implicate a mitochondrial bottleneck during
female germ cell development7,8, but the precise mechanism is a
source of debate. Several studies have measured an evolu-
tionary conserved physical reduction in cellular mtDNA content
within the developing germ line8–12. Statistical genetic theory and
in silico modelling show the measured reduction in mtDNA
content is sufficient to cause different heteroplasmy levels in
siblings13, but there is no direct experimental evidence showing
that the reduction in mtDNA levels is essential for mtDNA
segregation. Moreover, the variation in heteroplasmy levels
(heteroplasmy variance) predicted by the models only accounts
for ~70% of the observed variance seen in offspring10, implicating
mechanisms other than the simple reduction of mtDNA copy
number.
Although the total amount of mtDNA within the embryo
remains constant during pre-implantation development10,11,14,
there is ongoing mtDNA turnover in pre-implantation
embryos15,16. This means that the measured reduction of
mtDNA within individual cells could be due to several mechan-
isms, including a reduction of the replication rate of mtDNA and
an increase in the destruction of mtDNA by autophagy16.
Resolving these issues at a cellular level will be challenging in
living organisms. For this reason, we developed an in vitro model
of the critical time point during early germ cell development,
allowing us to study mitochondria and mtDNA at the cellular and
sub-cellular level during and immediately before germ cell
specification.
Results
Low oxygen tension generates a genetic bottleneck before
PGCLC specification and modulates heteroplasmy segregation.
Embryonic stem cells (ESCs) were isolated from mice carrying
two transgenic reporter genes, Blimp1-mVenus (BV) and Stella-
ECFP (SC), allowing the identification and isolation of primordial
germ cell-like cells (PGCLCs) throughout their in vitro
development17,18. Using ultra-high-depth mtDNA sequencing
(mean coverage 2869-fold, SD: 909) of BVSC ESC, we detected
heteroplasmic mtDNA variants (Supplementary Data 3), as seen
in human stem cell lines19. We subcloned a BVSC ESC line
(Fig. S1a) and identified an ESC clone that did not contain
detectable heteroplasmic mtDNA variants (homoplasmic WT),
and a second ESC clone harbouring a highly conserved hetero-
plasmic variant in mt-Nd1 (m.3062T > A/mt-Nd1, ND1:p.F104V)
(Fig. S1b and Supplementary Data 3) with a mean heteroplasmy
of 29.6% stable over five passages before differentiation (there-
after called ND1) (Fig. S1c). The ND1 cell line had a 17%
reduction in oxygen consumption compared to the WT
(Fig. S1d), with no difference in glycolysis activation (Fig. S1e),
consistent with mild defect of mitochondrial respiration.
The conventional protocol for in vitro PGCLC differentiation
is performed at 20% oxygen and requires the specification of ESC
to epiblast-like cells (EpiLCs, for 2 days, D2) (Figs. 1a and S1f)
followed by the expression of BV (from D3 onwards) and SC
(Fig. 1a), recapitulating the in vivo gene expression profile of
primordial germ cells (PGCs)20. In order to investigate the
segregation of the heteroplasmic ND1 variant during the early
stages of PGC development, PGCLCs were generated using the
two isogenic ESC subclones (WT and ND1, Fig. 1b)21 that
sequentially expressed the BV followed by the SC transgenic
reporter genes (Fig. 1c and S1g, h). Measuring the number of
BVSC(+) cells isolated at the same time point showed a reduced
rate of proliferation for the differentiating ND1 line, consistent
with the observed oxygen consumption defect (Fig. S1i). The
mtDNA content was measured in single BV(+) and BVSC(+)
cells from 3 independent experiments (Fig. 1d and Supplemen-
tary Data 1). ND1 cells showed a constant mtDNA content while
the WT cells displayed a slight decrease at D5 of differentiation in
comparison to their counterpart (Fig. 1d and Supplementary
Data 1). The mtDNA content on both cell lines was ~5-fold
greater than the ~200 copies per cell measured in early mouse
PGCs in vivo9–11, indicating that germ cell specification does not,
on its own, lead to a mtDNA genetic bottleneck.
In utero, the oxygen concentration progressively goes down as
the embryo reaches the uterus (Fig. 1e)22,23, in line with in vitro
studies showing that a low oxygen concentration leads to a higher
efficiency of early embryo development. During this period of
pre-implantation development, the mtDNA content of the whole
embryo remains constant, while the mtDNA copy number per
cell drops10,11,24. Vascularisation of the embryo occurs post-
implantation, between ~E6.5 and E9.525,26, which also corre-
sponds to the time of PGCs specification. Consequently, the
oxygen concentration within the embryo progressively increases22
in order to support its development. We speculated that the
reduction of oxygen concentration during the early stages of the
embryo development was required for the decrease of the
mtDNA content. To support this, we took advantage of available
single-cell (sc) RNA-seq data collected from whole mouse
embryos at E4.5 and E7.527. Our re-analysis showed that at
E4.5, blastocysts expressed significantly more OXPHOS-related
genes than later stage E7.5 embryos (p-value= 10−1 24; Figs. 1e
and S2a), consistent with a lower oxygen concentration at E7.5
coinciding with the mtDNA bottleneck in vivo. To model the
variation of oxygen levels during the early developmental
stages in vivo (Fig. 1e), we adapted the differentiation protocol
so that the first four days of the PGCLC specification were at low
(3%) oxygen level, followed by high (20%) oxygen level for the
last 24 h.
As a first step, we maintained ESCs at 3% oxygen. This led to a
stable decrease in mtDNA content (Fig. S2a–d) without
decreasing the mitochondrial mass (Fig. S2e) as seen previously28.
To determine whether low oxygen levels could lead to a genetic
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bottleneck during differentiation, we used the modified protocol
(Figs. 1e, f and S3a) to isolate BV(+) (from D4 to D6) and BVSC
(+) (at D7) cells by fluorescence-activated cell sorting (FACS)
from both the WT and ND1 lines from 4 independent
experiments (Fig. S3b–d). Analysis of the mtDNA content in
single cells measured from WT BV(+) cells showed an ~4-fold
decrease in the mean mtDNA content from 1119 (SD: ±495
copies) at D4 to 319 (SD: ±300 copies) at D6 (Fig. 1g and
Supplementary Data 1). We saw a similar pattern for the
ND1 cells (4-fold, 1240 copies, SD: ±513 copies at D4; 249 copies,
SD: ±294 copies at D6) (Fig. 1g and Supplementary Data 1). At
D7 of differentiation, the mtDNA copy number increased to 1434
(SD: ±495 copies) and 1462 (SD: ±513 copies) in WT and ND1
BVSC(+), respectively (Fig. 1g and Supplementary Data 1). SC
expression and the increase in mtDNA content were prevented if
the cells were maintained at low oxygen concentrations beyond
D6 (Fig. S3e–g). Importantly, the culture conditions at low
oxygen concentration did not affect cell viability (Fig. S3h), nor
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the subsequent expression of BVSC, which was similar to cells
differentiated in 20% oxygen.
Given our previous findings, next we determined whether the
reduction of mtDNA copy number generated by low oxygen level
influenced the segregation of mtDNA heteroplasmy. We studied
single-cell measurements taken throughout the differentiation
process of the heteroplasmic ND1 line. In 20% oxygen, when the
cells maintained their mtDNA content (Fig. 1h and Supplemen-
tary Data 1), the heteroplasmic mt-ND1 variant did not segregate.
However, in 3% oxygen, the observed reduction in mtDNA
content in BVSC(+) cells was accompanied by an increase in the
heteroplasmy variance (Fig. 1i and Supplementary Data 1). Taken
together, our data suggest that oxygen concentration modulates
the heteroplasmy segregation.
The genetic bottleneck is accompanied by a reduction in the
number of mtDNA-replicating foci, but no activation of
autophagy. The decrease of mtDNA content per cell during the
early stages of embryogenesis is believed to be due to the sub-
compartmentalisation of a fixed number of mtDNA molecules
with each cell division10,11. However, given evidence of ongoing
mtDNA turnover15, other mechanisms could also play a part.
First, we measured the cell proliferation rate during PGCLC
differentiation which did not correlate directly with cell-mtDNA
levels (Fig. S4a, b), pointing towards other mechanisms. Next, we
studied mtDNA replication using the thymidine analogue 5-
ethynyl-2′-deoxyuridine (EDU)29 which co-localised with the
mitochondrial outer-membrane marker TOM20 at the single-cell
level (Figs. 2a and S4c, Supplemental Video 1 and Supplementary
Data 1). Each cell line was pulsed with EDU for 30 min, enabling
a measurement of the number of active replicating foci, which
reflects the mtDNA replication rate30. At 3% oxygen, the number
of replicating foci per cell showed a progressive trend to decrease
in both WT and ND1 BV(+) cells (Figs. 2a and S4c, and Sup-
plementary Data 1), in keeping with the ~4-fold decrease of
mtDNA content. The replication of the mtDNA in the WT cells
at 20% O2 was also reduced from D4 to D5, but less so, corre-
sponding to the slight reduction of mtDNA observed at D5
(Figs. 1d, 2a and S4c, and Supplementary Data 1). By contrast, the
number of replicating foci in the ND1 BVSC(+) cells remained
unchanged at 20% oxygen, consistent with the constant mtDNA
copy number observed during the differentiation (Figs. 2a
and S4c, and Supplementary Data 1). Taken together, this showed
that the reduction of mtDNA copy number in cells correlates with
a decrease of mtDNA replication rate in keeping with this playing
a role in the bottleneck mechanism. However, the lack of a
complete correspondence between replicating foci and mtDNA
levels, particularly on D7, indicates that other mechanisms must
also come in to play.
Intensive fragmentation of the mitochondrial network would
allow the degradation of mtDNA molecules through the
autophagy of individual mitochondria16, and thus contribute to
the bottleneck mechanism. In keeping with this, we observed
fragmentation of the mitochondrial network in BV(+) cells at low
oxygen concentrations, with a significant reduction of the mean
length of mitochondria (Fig. S4c). To determine whether
autophagy was playing a role in the mtDNA bottleneck, we
studied ATG12 which is recruited to the pre-autophagosomal
structure31,32. In both the WT and ND1 cell lines, at D6, BV(+)
cells containing a low level of mtDNA also expressed low levels of
ATG12 protein (Figs. 2b and S5a, and Supplementary Data 1).
The increased mtDNA content at D6 to D7 (Fig. 1g) when cells
were differentiated using the modified protocol occurred along
with an increase of ATG12 level (Figs. 2b and Fig. S5a, and
Supplementary Data 1). Together, these findings make it unlikely
that ATG12-mediated autophagy is involved in the regulation of
mtDNA content during PGC differentiation.
Unequal partitioning of mitochondria in BVSC(−) cells. In
addition to the well-established germ line genetic bottleneck,
several studies have shown a reduction of mtDNA content in
somatic tissues during early development8,9,12. Potentially, this
could contribute to the segregation of mtDNA heteroplasmy in
developing tissues and organs, leading to high mutation loads in
vulnerable tissues, which cause disease33. To explore this, we
studied BVSC(−) single cells isolated from WT and ND1 cell
lines throughout their specification process (Fig. S6a). It is likely
that this cell population is heterogeneous, and although we did
not characterise them in detail, a proportion are likely to develop
into committed somatic tissues20. At 20% oxygen, in contrast to
the PGCLCs, we saw a 1.5- and 2.5-fold-change decrease in
mtDNA levels in the WT and ND1 cell lines, respectively (WT
D4: mean of 1027 copies, SD: ±535 copies; WT D6: mean of 690
copies, SD: ±306 copies; ND1 D4: mean of 1559 copies, SD: ±606
Fig. 1 Low oxygen tension generates a genetic bottleneck before PGCLC specification and modulates the heteroplasmy segregation. a Scheme
highlighting the conventional protocol for PGCLC differentiation. b Differentiation monitoring at 20% oxygen. Representative microscopy confocal imaging.
White arrows show PGCLCs. Scale bars= 100 µm. c Percentages of the BVSC(+) events acquired by FACS (mean ± SEM, n= 4 independent
differentiation, **p < 0.01, two-way ANOVA with multiple comparisons using Sidak test). d Number of mtDNA molecules per single cell. Horizontal lines
represent mean, **p < 0.01, two-way ANOVA with multiple comparisons using Sidak test (for WT cells, D4: 41 cells; D5: 45 cells; D6: 43 cells; D7: 40; for
ND1 cells, D4: 37 cells; D5: 40 cells; D6: 39 cells; D7: 43 cells from 3 independent differentiations). e Cartoon representing primordial germ cell (PGC)
specification in vivo (top panel) illustrating the local oxygen levels during pre- and post-implantation development. The intermediate panel summarises the
metabolism of embryos at E4.5 and E7.5 based on the transcriptomic analysis performed and shown in Fig. S2a. The bottom panel shows the modified
in vitro protocol for specification of PGCLCs, modelling the increased oxygen requirement in vivo. In vitro epiblast-like cells (EpiLCs), epiblast-like cells
in vivo, begin differentiation in a low oxygen concentration. From D6 to D7, the oxygen concentration is increased, which is essential for Stella expression in
PGCLCs corresponding to PGCs at E7.25. Blue= low oxygen, red= high oxygen. f Monitoring of the differentiation of ND1 cells performed at various
concentrations of oxygen. Representative microscopy confocal imaging. White arrows show PGCLCs. Scale bars= 100 µm. g Number of mtDNA molecules
per single WT and ND1 cells using the modified protocol of differentiation. Horizontal lines represent mean, ****p < 0.0001 two-way ANOVA with multiple
comparisons using Sidak test (WT, D4: 40 cells; D5: 57 cells; D6: 56 cells; D7: 45; ND1, D4: 44 cells; D5: 61 cells; D6: 63 cells; D7: 44 cells from 3
independent differentiations). h Heteroplasmy measurements of m.3062T > A:p.mt-ND1 per cell in BV (yellow) and in BVSC (blue range)-positive cells
during differentiation at 20% oxygen (D4: 70 cells, n= 4, variance: 0.024; D5: 63 cells, n= 4, variance: 0.031; D6: 59 cells, n= 4, variance: 0.032; D7: 76
cells, n= 4, variance: 0.017). i Heteroplasmy measurements of m.3062T > A:p.mt-ND1 per cell in BV(+) (blue range at D4, D5 and D6 at 3% oxygen
concentration) and in BVSC(+) (red, at D7 at 20% oxygen concentration) cells (D4: 46 cells, n= 3, variance: 0.020; D5: 60 cells, n= 4, variance: 0.025;
D6: 58 cells, n= 4, variance: 0.041; D7: 45 cells, n= 3, variance: 0.036). The horizontal lines represent mean, *p > 0.1 with a one-sided bootstrap
confidence interval test (50k iterations) for whether the variance was greater at a later time point relative to D4, with Benjamini-Hochberg correction with
false-discovery rate= 0.1.
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copies; ND1 D6: mean of 606 copies, SD: ±223 copies corre-
sponding to a >1.5-fold-change decrease in WT BVSC(−) and
>2.5-fold-change decrease in ND1 BVSC(−), respectively;
Fig. S6b, c). However, at low oxygen tensions (3%), we observed a
>4-fold decrease of mtDNA content in BVSC(−), similar to the
adjacent PGCLCs at D6 (WT D4: mean of 1003 copies, SD: ±472
copies; WT D6: mean of 212 copies, SD: ±160 copies; ND1 D4:
mean of 1207 copies, SD: ±494 copies; ND1 D6: mean of 133
copies, SD: ±106 copies; Fig. S6d, e). These findings resem-
ble observations in vivo where somatic cell genetic bottlenecks
have also been shown in mice, zebrafish and humans8,9,12, but
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modulated in part by the oxygen concentration in BVSC(−) cells
(Fig. S6f).
Next, we studied the consequences of oxygen concentration on
the segregation of ND1 heteroplasmy in the BVSC(−) cells. As
expected, at 20% oxygen levels, the presence of a genetic
bottleneck was linked to heteroplasmy segregation (Fig. 3a and
Supplementary Data 1). However, at 3% oxygen we also saw a
decrease in the median heteroplasmy level from D4 (median=
26) to D7 (median= 12, p= 0.0065) consistent with negative
selection acting against the m.3062T > A/mt-Nd1 variant in
somatic cells (Fig. 3b and Supplementary Data 1). Hence, the
oxygen tension altered the outcome of the heteroplasmy
segregation in BVSC(−) cells. As expected, the mtDNA
replication rate was decreased in both 20% and 3% of oxygen
in keeping with a reduced mtDNA content (Fig. S6g). Moreover,
ATG12 levels in BVSC(−) cells were found to be lower than in
BV(+) and BVSC(+) emphasising an autophagy-independent
mechanism responsible for mtDNA genetic bottleneck
(Fig. S5a–c). It also suggested that autophagy was not involved
during the negative selection of the heteroplasmic mt-ND1
variant observed at 3% O2 despite displaying fragmented
mitochondria (Fig. S7).
The unequal partitioning of mitochondria has been proposed
to contribute to heteroplasmy segregation11. We therefore
investigated the distribution of mitochondria during differentia-
tion in BV(+), BVSC(+) and BVSC(−) cells using the IMARIS
referential frame reduction function to study the cells in three-
dimensions. The mitochondria remained evenly distributed
throughout the cytoplasm in both the WT and ND1 cells at
20% oxygen level (Fig. 3c). However, at 3% oxygen, the WT and
ND1 BVSC(−) cells had more polarised mitochondria compared
to the BV(+) cells (Fig. 3c). Thus, in our in vitro model, the
asymmetric compartmentalisation of mitochondria could also
contribute to the segregation of mtDNA heteroplasmy in BVSC
(−) cells at low oxygen concentrations. Although unlikely to play
an important role during early PGCLC development, we cannot
exclude asymmetric compartmentalisation being at stake in germ
line heteroplasmy segregation at later stages.
Oxygen tension modulates the expression of genes involved in
the replication of mtDNA, but not autophagy. To further
investigate the impact of oxygen tension upon mtDNA replica-
tion, we performed sc-RNA-seq during in vitro differentiation of
WT cells from D4 to D7 in 3 independent experiments at 20%
and 3% of oxygen (Fig. 1a, e). In total, we analysed the tran-
scriptome from 740 single cells.
First, we analysed the expression of lineage-specific genes12 in
cells isolated at D7 (Fig. S8a). Unbiased hierarchical clustering did
not distinguish BVSC(+) cells generated using the conventional
(20% oxygen) protocol from the modified (3% oxygen) protocol.
This indicates that, under both conditions, we generated near-
identical PGCLCs from ESCs in vitro. Next, we identified genes
that were differentially expressed between high- and low-oxygen
conditions from D4 to D7 (Fig. 4a). The transcriptomes diverged
the most at D5 and D6 (Fig. 4a), which also correspond to the
lowest levels of mtDNA (Fig. 1g). The in vitro genetic bottleneck
occurred alongside the metabolic shift from a predominant
OXPHOS-dependent to a more balanced metabolism (significant
glycolytic activity increase with p-value= 2 × 10−7; Fig. 4b and
Supplementary Data 2), closely resembling the metabolic profile
of cells at E7.5 in vivo27, and corresponding to the in vivo
mtDNA bottleneck10 (Figs. 1e and S2a).
Next, we focussed on genes involved in the mtDNA replication,
calculating a score reflecting the number of mtDNA-replication-
related genes (Supplementary Data 2) expressed per cell on each
day of in vitro development. Less replication genes were expressed
in cells under low-oxygen conditions than those under high-
oxygen conditions between D5 and D7 (Fig. 4c, p-value= 0.0004),
and the number of genes expressed at D5 was significantly lower
at 3% oxygen (Fig. S8b; p-value= 0.011). Similarly, BVSC(−) cells
displayed lower expression of mtDNA-replication-related genes in
comparison to BVSC(+) (p-value= 7.5 × 10−22, Fig. S8c). These
data support our earlier observations, implicating a reduction of
mtDNA replication in generating the mtDNA genetic bottleneck.
To illustrate this, we compared two specific genes: (1) the
mitochondrial genome maintenance exonuclease 1 (Mgme1)
shown to be involved in the degradation of linear double-
stranded mtDNA during replication34 and (2) the mitochondrial
methylenetetrahydrofolate dehydrogenases (Mthfd2), member of
the folate-mediated one-carbon metabolism that supports mtDNA
replication via the nucleotide synthesis within the organelle35. At
20% O2, these two genes appeared to be co-expressed throughout
the differentiation process (Fig. 4d) suggesting a balance between
mtDNA degradation and replication in line with a constant
mtDNA content as well as number of mtDNA-replicating foci.
However, at low oxygen concentration, Mgme1 expression was
significantly increased from D4 to D5 (Figs. 4e and S8d, p-value=
0.0012). Mthfd2 level remained constant from D4 to D5 with a
significantly reduced expression when compared to 20% O2 at D5
(Fig. S8d, p-value= 0.0034), implying a disruption of the balance
between mtDNA degradation and replication (Fig. 4e) potentially
contributing to the drop in mtDNA copy number. In line with
this, at D7 after differentiation using the modified protocol, the
Fig. 2 The genetic bottleneck is associated with a reduction of mtDNA replication, but no autophagy activation. a Representative microscopy confocal
staining images of TOM20 surface (red, upper) and pulse-labelled with EDU spot (purple, lower) surfaces generated by IMARIS software based on
fluorescent intensity signal of BV(+) and BVSC(+) cells during PGCLC differentiation. Scale bars= 2 µm. Original images showing the fluorescent
intensity are shown in Fig. S4c. Respective quantification of the relative number of EDU spots per cell are shown (colour code of the left panel reflects
the concentration of oxygen; colour code of the right panel reflects the expression of BV (yellow) and BVSC(blue) cells). Horizontal bars represent
the mean, *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001, one-way ANOVA with multiple comparisons using Tukey test relative to D7 (WT 3% O2,
D4: 25 cells, n= 3; D5: 24 cells, n= 3; D6: 26 cells, n= 3; D7: 16 cells, n= 2; ND1 3% O2, D4: 19 cells, n= 3; D5: 17 cells, n= 3; D6: 24 cells, n= 3; D7: 13
cells, n= 2; WT 20% O2, D4: 16 cells, n= 3; D5: 25 cells, n= 3; D6: 15 cells, n= 3; D7: 20 cells, n= 3; ND1 20% O2, D4: 23 cells, n= 3; D5: 10 cells, n= 2;
D6: 9 cells, n= 2; D7: 20 cells, n= 3). b Representative microscopy confocal staining images of ATP5a surface (red) and ATG12 surfaces (white)
generated by IMARIS software based on fluorescent intensity signal of BV(+) and BVSC(+) cells at D6 and D7 of differentiation of WT and ND1 using
either the conventional or the modified protocol. Scale bars= 2 µm. Original images showing the fluorescent intensity are available in Fig. S5a.
ATG12 surface volume per WT and ND1 cells quantifications at 20% O2 (red, BVSC(+)) and 3% O2 (blue, BV(+)) at D6 of differentiation shown on the top
right panels. The horizontal lines represent the mean, *p < 0.05, **p < 0.01 Student’s t-test (WT-BVSC(+): 11 cells, n= 2; WT-BV(+): 14 cells, n= 2; ND1-
BVSC(+): 9 cells, n= 2; ND1-BV(+): 9 cells, n= 2). ATG12 surface volume comparison BV(+) cells (red, 3% oxygen, D6) and BVSC(+) cells (blue, 20%
oxygen for 24 h, D7) cells shown on the bottom-right panel (‘Modified Protocol’). The horizontal lines represent the mean, ***p < 0.001, Student’s t-test
(WT: D6: 14 cells, n= 3; D7: 12 cells, n= 3; ND1: D6: 9 cells, n= 2; D7: 18 cells, n= 3).
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expression of these two genes is once again balanced out (Fig. 4e).
Indeed, we observed a significant increase in Mthfd2 expression
from D6 to D7 (Figs. 4e and S8d, p-value= 0.016) combined with
a reduction of Mgme1 expression in low compared to high
oxygen concentrations (Fig. S8d, p-value= 0.037), correlating with
the increase of mtDNA copy number observed at this stage
(Fig. 1g). Taken together, this supports a role for mtDNA
replication as an important mechanism in the generation of the
mtDNA genetic bottleneck, and it also illustrates the complexity of
its regulation.
Finally, we investigated the expression of genes involved in
mitochondrial dynamics at D5 of differentiation. These pointed
towards a more fragmented mitochondrial network at low oxygen
concentrations, which correlated with the decreased mtDNA
content, particularly involving Drp1, Yme1l1 and Bnip3 (Fig. S9a).
Nonetheless and in keeping with our previous observations
(Fig. 2b), there was no difference in autophagy-related gene
expression between the conventional and modified protocol at D5
(Fig. S9b and Supplementary Data 2), and similar expression
levels for genes linked to lysosomal activity throughout the
differentiation process (Fig. S9c and Supplementary Data 2).
Thus, the RNA-seq data support our earlier conclusion that
autophagy are not primary mechanisms generating the mtDNA
genetic bottleneck.
Discussion
In several vertebrate species, the amount of mtDNA falls to low
levels in the developing female germ line shortly after implanta-
tion of the blastocyst7,8,10,11. In silico simulations and statistical
modelling suggest that the reduction in mtDNA content is suf-
ficient to contribute to a genetic bottleneck leading to an increase
in the heteroplasmy variance in the oocyte population13, but there
is limited direct experimental evidence to support this.






























































































































































a Modified ProtocolConventional Protocol
Fig. 3 Tissue-specific mechanism of segregation: unequal partitioning of mitochondria in BVSC(−). a Heteroplasmy measurements of m.3062 T > A:p.
mt-nd1 per cell in BVSC(−) cells during differentiation at 20% oxygen (D4: 55 cells, n= 4, variance: 0.015; D5: 64 cells, n= 4, variance: 0.027; D6: 58
cells, n= 4, variance: 0.032; D7: 75 cells, n= 4, variance: 0.024). b Heteroplasmy measurements of m.3062T > A:p.mt-nd1 per cell in BVSC(−) cells during
differentiation at 3% oxygen (D4: 47 cells, n= 3; D5: 61 cells, n= 4; D6: 51 cells, n= 4; D7: 39 cells, n= 3). The horizontal lines represent mean, *p > 0.1,
**p > 0.05 with a one-sided bootstrap confidence interval test (50k iterations) for whether the variance was greater at a later time point relative to D4, with
Benjamini-Hochberg correction with false-discovery rate= 0.1. c Representative mitochondrial distribution (TOM20, red) in BVSC(−), BV(+) and BVSC(+)
cells at D6 in both WT and ND1 cells when cultured at either 20% or 3% oxygen. Mitochondrial spots on the surface (white dots) were counted in the 3D
space according to a reference point. Respective quantifications are shown on the right panels. The data represent a box plot, *p < 0.05 Student’s t-test,
(WT BVSC(+) 20% O2: 16 cells, n= 3; WT BVSC(−) 20% O2: 16 cells, n= 2; ND1 BVSC(+) 20% O2: 18 cells, n= 3; ND1 BVSC(−) 20% O2: 22 cells, n= 3;
WT BV(+) 3% O2: 23 cells, n= 3; WT BVSC(−) 3% O2: 21 cells, n= 3; ND1 BV(+) 3% O2: 16 cells, n= 3; ND1 BVSC(−) 3% O2: 22 cells, n= 3).
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Fig. 4 Single-cell RNA sequencing in BVSC(+/−) cells during WT cell differentiation in high and low oxygen concentrations. a Volcano plots showing
the differentially expressed genes for each day between positive cells differentiating with the conventional (20% oxygen) and the modified (3% oxygen)
protocol. Coloured dots represent significantly up-regulated (purple) and down-regulated (green) genes with multiple-testing corrected p-value < 0.05, as
identified by Wilcoxon rank-sum tests (20% O2: D4: 47 cells, D5: 40 cells, D6: 45 cells, D7: 48 cells, n= 3; 3% O2: D4: 40 cells, D5: 48 cells, D6: 48 cells,
D7: 48 cells, n= 3). b Scatter plots with marginal distributions showing the metabolism-related gene expressions in PGCLC at D5 and D6 (data combined
together) when differentiated at low (blue) and high (red) oxygen concentration. Each dot represents a single cell. Its (x,y) coordinates are calculated by
the number of genes expressed related to glycolytic (y axis) and OXPHOS (x axis) metabolism. Data consider the expression of 85 glycolytic genes and 96
OXPHOS genes (Supplementary Data 2). OXPHOS activity p-value= 4 × 10−3, glycolytic activity p-value= 2 × 10−7, Wilcoxon rank-sum tests were
applied with significance threshold of 0.05 for DEG discovery, and Benjamini-Hochberg procedure was used to obtain multiple-testing corrected p-values
(3% O2: 96 cells; 20% O2: 85 cells; n= 3). c Line plot showing the number of mtDNA-replication-related genes expressed per cell (mtDNA replication
score, x axis) during PGCLC differentiation using the conventional protocol (red, 180 cells, n= 3) and modified protocol (blue, 184 cells, n= 3). The
mtDNA replication score is calculated based on the expression of 18 genes (Supplementary Data 2), p-value= 0.0004, Wilcoxon rank-sum tests were
applied with significance threshold of 0.05 for DEG discovery, and Benjamini-Hochberg procedure was used to obtain multiple-testing corrected p-values.
d, e Mgme1 and Mthfd2 gene expressions during PGCLC differentiation at 20% (d) and 3% (e) oxygen concentration. Data represent the median of read
counts ± SD. Wilcoxon rank-sum tests were applied with significance threshold of 0.05 for Differentially Expressed Gene (DEG) discovery and Benjamini-
Hochberg procedure was used to obtain multiple-testing corrected p-values.
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Here we show that heteroplasmy segregation of the mt-Nd1
variant occurs only under the conditions when mtDNA levels are
low. The observed reduction in mtDNA content at 3% oxygen
levels closely resembles the mtDNA genetic bottleneck measured
in single cells in mice in vivo10–12, and suggests that low oxygen
tension contributes to the formation of a mtDNA genetic bot-
tleneck. In vivo measurements of the mtDNA bottleneck have
only been made on committed PGCs, defined by alkaline phos-
phatase staining, or Stella (SC) expression. However, the in vitro
model allows the isolation of pre-PGCLCs based on BV(+)
expression, which is not technically possible in vivo. The mtDNA
levels were lowest in the BV(+) cells, indicating that the lowest
cellular mtDNA content (or the ‘narrowest’ part of the bottle-
neck), is actually immediately before the PGCLC stage. Experi-
mentally raising the oxygen concentration prevented the
reduction in mtDNA content, and abolished heteroplasmy seg-
regation in PGCLCs confirming the importance of local oxygen
levels, and showing that the reduction in mtDNA content is
required for the genetic bottleneck mechanism. Although it is
possible that the PGCLCs we generated at 3% oxygen were not
developmentally competent, we think this is highly unlikely
because they were generated at the same frequency without
showing signs of stress (autophagy and cell viability), had near-
identical expression profiles for key developmental genes and
expressed the same lineage-specific cell markers. It therefore
seems highly likely that changes in the local cellular micro-
environment during and after implantation are playing a key role
in driving the mtDNA genetic bottleneck itself, and thus is
important for the segregation of mtDNA heteroplasmy.
Establishing an in vitro model has also cast light on sub-
cellular mechanisms contributing to the bottleneck. In ESCs,
mtDNA levels remained stable at ~1100 copies despite ongoing
cell division over 9 passages, consistent with an active control
mechanism regulating the intracellular mtDNA content (Fig. S1i).
However, the induction of differentiation led to a reduction in
mtDNA levels regardless of the cell proliferation rates, associated
with a reduction in the number of mtDNA-replicating foci per
cell. Although, based on our data, the reduction in replicating foci
cannot completely account for the mtDNA bottleneck, sc-RNA-
seq data independently endorse the importance of mtDNA
replication in the bottleneck mechanism, and points towards an
active mechanism reducing the intracellular mtDNA content.
Finally, given that each mtDNA nucleoid is thought to contain
~1.4 mtDNA molecules, only a minority of the mtDNA nucleoids
were actively replicating at any one time. It is therefore possible
that this ‘sub-sampling’ also contributes to the overall bottleneck
mechanism in vivo11, explaining why simple models based only
on total-cell mtDNA levels only account for ~70% variance in
heteroplasmy seen in the next generation10.
It is striking that we observed an important range of mtDNA
copy number per cell at all stages of the differentiation. These
differences could reflect the precise developmental stage of each
cell36,37, which is unlikely to be completely synchronised, natural
fluctuations in mtDNA content accompanying the cell cycle38, or
conceivably, local differences in oxygen concentration. Recent
evidence has shown heterogeneity in the oxygen concentration
within individual cultured cells39,40. This is also likely to be the
case in our experiments, potentially explaining why BV(+), BVSC
(+) and BVSC(−) cells showed a wide range in their mtDNA
content at every developmental stage. Similar cell heterogeneity is
also likely in vivo, also explaining the range of mtDNA levels seen
in PGCs and somatic cells10,11. Although this means that we
cannot make a definitive statement about a specific oxygen con-
centration that is required to cause the mtDNA bottleneck, our
main conclusion—that oxygen levels modulate the mtDNA bot-
tleneck—still holds true. Different pathogenic mtDNA mutations
can also influence the cellular oxygen consumption to differing
degrees, and thus potentially influence the cellular micro-
environment when oxygen is limited. It is therefore plausible
that the mutations themselves alter the intracellular mtDNA
content, as seen in blood cells41. If this also occurs within PGCs at
a critical stage of development in vivo, it would lead to mtDNA
bottlenecks of different ‘strengths’, as seen in families transmit-
ting pathogenic mtDNA mutations where m.8993T > G segre-
gates more rapidly than other pathogenic mtDNA mutations42. It
will therefore be important to study other mtDNA variants in our
in vitro system, to determine whether they behave in a similar
way to the mt-Nd1 variant we studied here.
Mutation-specific heteroplasmy segregation has also been
observed in mice43,44, and in Drosophila, where specific variants
undergo ‘selfish’ propagation during oogenesis45, or undergo
purifying selection linked to mitochondrial fragmentation and
mitophagy/autophagy46. In our in vitro model, BVSC(+) cells
showed high ATG12 levels, but we saw no evidence of selection
against the mt-Nd1 variant at that time point. On the other hand,
although we did see the signature of selection in BVSC(−) cells,
this was not associated with ATG12 activation, nor any evidence
of transcriptional activation of autophagy mechanisms (Fig. S9d,
p-value= 0.0005). Taken together, these findings indicate that
ATG12-mediated autophagy is unlikely to be involved in selec-
tion at this stage of development. However, it is important to note
that our observations do not exclude the possibility that ATG12 is
involved in selection at a later stage, or that there is an ATG12-
independent mechanism as previously proposed46. The selection
in BVSC(−) cells could be occurring at several levels: at the
mtDNA level, at the organelle level or at the cellular level. The
absence of ATG12 activation in the ND1 BVSC(−) cells suggests
that the selection is not occurring at the sub-cellular level.
However, the mitochondrial polarisation we observed could
contribute to the selection through the unequal partitioning of
heteroplasmy during cell division. It is also possible that differ-
ences in cell proliferation are involved. In keeping with this, we
noted that BVSC(−) cells proliferated faster than the BVSC(+)
cells. If BVSC(−) cells containing high levels of the ND1 variant
proliferated slower due to the mild defect of mitochondrial
respiration, this would contribute to a reduction in the average
mutation load. The signature of selection that we observed in
BVSC(−) cells contrasts with findings in human embryos12,
where selection was observed in PGCs but not in adjacent somatic
tissues. However, Floros et al.12 studied low-level mtDNA het-
eroplasmies across the whole mitochondrial genome, and focus-
sed on a later stage of post-implantation development. Different
selection mechanisms are known to act at different points during
transmission44,47, potentially explaining these differences and
highlighting the complexity of heteroplasmy inheritance
mechanisms, which may be mutation dependant.
Our observations show that oxygen is likely to make an
important contribution to the mtDNA bottleneck. Validating this
in vivo could open up new approaches to influence heteroplasmy
levels in somatic cells and within the germ line, and thus open
new therapeutic avenues to treat and prevent mtDNA diseases.
Methods
Embryonic stem cell maintenance and coating procedures. ESCs were cultured
in a 2i+ LIF medium as previously described21. Briefly, ESCs were cultured in
poly-L-ornithine (0.01%; Sigma) and laminin (10 ng/ml; Sigma) pre-coated 6-well
plates in N2B27 medium supplemented with 2i (CHIR99021, 3 μM: Stemgent;
PD0325901, 0.4 μM: Stemgent) and LIF (103 units/ml; Millipore). The expended
colonies were passaged every other day by TrypLE (Invitrogen) dissociation. Plate
coating was performed for 1 h at room temperature (RT) with poly-L-ornithine
and for 1 h at 37 °C with laminin. Plates were washed with PBS (Invitrogen) before
cell plating.
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DNA extraction from single cells. Single ESCs were sorted in 96-well plate and
lysed for 30 min at 37 °C in 4 µl of 50 mM Tris-HCL, pH 8.5, with 0.5% Tween20
and 200 ng/ml proteinase K (Ambion) followed by 15 min of inactivation by
heating at 80 °C.
Deep sequencing and variant analysis. mtDNA was amplified using PrimeSTAR
GXL DNA polymerase (Takara) in two overlapping fragments (Amplicon 1, for-
ward primer: AGCAAAAGCCCACTTCGCCA, reverse primer
GGTTGGCCCCCAATTCAGGT; Amplicon 2, forward primer:
ACCTGAATTGGGGGCCAACC, reverse primer
TGGCGAAGTGGGCTTTTGCT)48. PCR products were assessed by gel electro-
phoresis and each amplicon was purified using Agencourt AMPure XP beads
(Beckman-coulter), quantified with a Qubit 2.0 fluorimeter (Invitrogen) and equal
concentrations of amplicon 1 and amplicon 2 from the same single cell were pulled
together to obtain a final concentration of 0.2 ng/µl. Library preparation was
performed using the Nextera DNA preparation kit (Illumina). Pooled amplicons
were tagmented, amplified, cleaned and pooled in equimolar concentrations. The
library was sequenced with a Mi-Seq Reagent Kit v2 for 600 cycles (Illumina) in
paired-end, 251 bp reads. Post-run FASTQ files were analysed using an in-house-
developed bioinformatics pipeline. Reads were aligned to the C57Bl6/J mouse
reference sequence using BWA49. Aligned reads were sorted and indexed using
Samtools50 and duplicated reads were removed using Picard (http://broadinstitute.
github.io/picard). Variant calling was performed in tandem using VarScan251.
Variants were annotated using ANNOVAR52 and heteroplasmic variants were
defined as >1% minor allele frequency.
Embryonic stem cell subcloning. Cells were seeded at low confluency (10,000 cells
per well) and single cells were picked using a mouth pipette under a Nikon
SMZ1000 microscope before to be transferred into a gelatin (0.1%)-coated 24-well
plate. Single cells were incubated at 5% CO2, 37 °C until ESC colony was visible
under microscope. The ESC colony was dissociated with trypsin and reseeded into
a 24-well plate coated with gelatin and incubated for 48 h at 37 °C with 5% CO2
before to be expanded and cultured as described in section ‘Embryonic stem cell
maintenance and coating procedures’.
Induction of EpiLCs and PGCLCs. Epiblast-like cell differentiation from ESCs and
PGC-like cell induction from EpiLCs were performed as described previously
unless specified otherwise21.
Fluorescence-activated cell sorting (FACS). FACS was monitored by the staff of
the cytometry facility at the Cambridge Institute for Medical Research (CIMR)
(University of Cambridge). Cell sorting was done using a high-speed influx cell
sorter (BD Biosciences) that has four lasers at 405, 488, 561 and 640 nm and is
equipped with 16 fluorescence detectors and a small particle detector. ESCs were
trypsinized, centrifuged and resuspended in 2i+ LIF medium. The cell suspension
was filtered using CellTrics 50 µm (Sysmex) in round-bottom polystyrene tubes
(Falcon). Tubes were kept on ice for DNA analysis purposes and at RT for
immunofluorescence (IF). Embryonic bodies were collected at various days of
differentiation and transferred to a 15 ml Falcon tube and centrifuged for 1 min at
200g. The supernatant was transferred to a new 15ml Falcon tube and kept at 37 °
C. Embryonic bodies were resuspended with 500 μl of trypsin supplemented with
ethylenediaminetetraacetic acid (Trypsin-EDTA) and incubated at 37 °C for 4, 7, 8
and 10 min at day 2, 3, 4 and 5 of the differentiation, respectively. The enzyme
activity was blocked by adding 500 μl of GMEM. The cell suspension was cen-
trifuged for 5 min at 200g at RT. The supernatant was aspirated. The pellet was
resuspended with the PGCLC medium kept at 37 °C and previously filtered. Cells
used to investigate the number of replicative mtDNA molecules were incubated for
1 h at 37 °C with EDU (1/1000). After incubation, cells were centrifuged and
resuspended in PGCLC medium. The cell suspensions were filtered using CellTrics
50 μM (Sysmex) in round-bottom polystyrene tubes (Falcon). Draq7 (1/1000;
Abcam) was added to each tube to assess cell viability. Tubes were kept on ice for
DNA analysis purposes and at RT for IF. Fluorescence intensity in the YFP channel
was plotted against the fluorescence intensity in the CFP channel21. Single cells
sorted in 96-well plates for DNA analysis were immediately put on dry ice before to
be stored at −80 °C. Cells used for immunochemistry were sorted by FACS
(between 200 and 500 cells) on coverslips coated with gelatin (0.1%) in a 24-well
plate. Cells were incubated in the plate for 30 min at 37 °C in either 20% or 3% of
oxygen for cell adhesion. Cells for cell cycle analysis were incubated with 2 µM
Hoechst. Gates were designed such that G1 and G2/M contain 5% of less positive
cells and 5% of the more positive cells for Hoechst intensity, respectively.
Mitochondrial DNA copy number measurements. Quantitative real-time PCR
(qPCR) was performed on a CFX96 Touch Real-Time PCR detection system (Bio-
Rad). mtDNA copy number was calculated using a Taqman assay targeting the
MT-ND5 gene (Forward primer: ACCTAATTAAACACATCAACTTCCC; Reverse
primer: GACTCAGTGCCAGGTTGTAA; Probe: HEX-ATTGCCTTTCTGACTA
GGTG-BHQ_1) and the β-actin gene (Forward primer: GATCGATGCCGGTGC
TAAGA; Reverse primer: GGAAAAGAGCCTCAGGGCAT; Probe: FAM- ACAC
CACCACATCAATCAAATTCTCCTTCA -BHQ_1). PCR-generated templates
were used to generate standard curve and make absolute quantification. Single-cell
mtDNA copy number measurements were carried out by Droplet Digital PCR
(ddPCR) according to the manufacturer’s instructions, using two mitochondrial
target mt-Nd1 (Forward primer: GAGCCTCAAACTCCAAATACTCACT; reverse
primer: GAACTGATAAAAGGATAATAGCTATGGTTACTTCA; probe
sequence: FAM-CCGTAGCCCAAACAAT-BHQ_1) and mt-Co3 (Forward primer:
CCTCGTACCAACACATGATCTAGG; reverse primer: AGTGGGACTTCTAGA
GGGTTAAGTG; probe sequence: HEX - ACCTCCAACAGGAATTTCA-BH
Q_1)53. Droplet analysis was performed using the QuantaSoft analysis software
(Bio-Rad). The absolute mtDNA copy number represents an average of the positive
droplets (HEX/FAM).
Western blotting. After migration, proteins were transferred to a polyvinylidene
difluoride membrane with the iBlot 2 Semi Dry Transfer system (Thermo Fisher
Scientific). iBlot2 protocol P0 (20 V for 1 min, 23 V for 4 min and 25 V for
remainder) was used for 7 min. Membranes were washed in Tris Buffer Saline with
Tween 20 (TBST) buffer made of 20 mM Tris hydrochloride pH 7 (Sigma-Aldrich),
0.5 mM NaCl (VWR, Lutterworth, UK) and 0.1% Tween 20 (Sigma-Aldrich)), and
then blocked with 5% (w/v) milk in TBST for 30–60 min. Primary antibodies were
incubated overnight at 4 °C (mt-Co1, ab14705, 1/1000; β-actin, a1978, 1/5000;
Mito-Cocktail, ab110413, 1/1000). The membrane was washed in TBST and
incubated with a secondary antibody for 1 h at RT. The protein signal was
developed with Clarity Western ECL Western Blotting substrate (Bio-Rad) for 5
min in the dark and imaged using the Amersham Imager 600 (GE Healthcare).
Densitometric analysis of the protein signal was performed using ImageQuant TL
8.1 software (GE Healthcare) and a ratio of the results, Protein constitutively
expressed/Protein of interest was calculated.
Mitochondrial respiration measurements. Mitochondrial oxygen consumption
rate (OCR) of WT and ND1 ESCs was analysed with SeahorseXFe24 Analyzer.
Final concentration of 1 µM Oligomycin, 1.5 µM FCCP and 1 µM Rotenone/1 µM
antimycin A was applied sequentially. After extracellular flux analysis, cells were
lysed in 20 µM lysis buffer and used for Bradford protein assay. Seahorse data were
normalised protein level.
Pyrosequencing. PCR primers and the sequencing primers were generated by the
PyroMark Assay Design Software (Qiagen). Forward primer: TCTATGAGTTCC
CCTACCAATACC; Biotinylated reverse primer: AAATTGTTTGGGCTACGGC;
Sequencing primer: TTTAAACCTAGGGATTTTAT54. Templates for pyr-
osequencing were amplified using the PyroMark amplification PCR kit (Qiagen)
using the manufacturer’s instructions. PCR amplification was programmed as
follows: 95 °C for 15 min as initial PCR activation step, then 45 cycles at 94 °C for
30 s for denaturation, 60 °C for 45 s for annealing and 72 °C for 30 s for extension.
A final extension step of 10 min at 72 °C clotures the PCR programme before the
samples were stored at 4 °C. Sequencing of the PCR amplicons was performed
using a PyroMark Q48 instrument (Qiagen) according to the manufacturer’s
instructions. Sequence analysis was performed using the PyroMark Supplementary
Software.
Immunocytochemistry. Cells were fixed with 4% paraformaldehyde (PFA) for 15
min at 37 °C in either 20% or 3% of oxygen. PFA was washed 3 times with 5%
foetal bovine serum (FBS)/PBS. PFA was quenched with a 10 mM NH4Cl/PBS for
10 min at RT in a humid chamber. NH4Cl/PBS was washed 3 times with 5% FBS/
PBS. Cells were permeabilized with 0.1X-Triton for 10 min at RT in a humid
chamber. Then, 0.1X-Triton was washed 3 times with 5% FBS/PBS. To investigate
the mtDNA replication, Click-iT EDU imaging kit was used following manu-
facturer’s instructions. The Click-iT reaction cocktail was prepared with Click-iT
reaction buffer, copper protectant, Alexa Fluorpicolyl Azid and reaction buffer
additive. The cocktail was incubated on a coverslip for 30 min at RT in a dark,
humid chamber. Cocktail was washed 3 times with 5% FBS/PBS29. Coverslips were
blocked for 20 min at RT in a dark, humid chamber. Cells were directly incubated
for 1 h at RT in a dark, humid chamber with rabbit anti-TOM20 (1:200 Abcam),
mouse anti-TOM20 (1:200 Abcam), mouse anti-ATP5a (1:200 Abcam) and rabbit
anti-ATG12 (1:200 Cell Signalling) prepared in 5% FBS/PBS. Coverslips were
washed 3 times with 5% FBS/PBS. TOM20 was revealed with a donkey anti-rabbit
Alexa 594 or anti-mouse Alexa 488 (1:1000), goat anti-mouse Alexa 594 (1:1000)
and a goat anti-rabbit Alexa 647 (1:1000). Secondary antibodies were incubated for
1 h at RT in a dark, humid chamber before to be washed 3 times with PBS.
Coverslips were washed with water and mounted on slides using a fluorescent
mounting media (Dako)55.
Confocal scanning imaging. Images of the Embryonic Bodies were acquired with
a LSM880 Axio Observer scanning system (Zeiss) using the lasers 458 nm (for
CFP) and 514 nm (for YFP) and the 10x/0.3 EC Plan Neofluar dry objective. All
images were acquired using the same parameters across the differentiation.
Confocal spinning disk imaging. Cell imaging was performed on an Andor
Dragonfly 500 confocal spinning disk system (Andor) using a Zyla 4.2 Megapixel
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PLUS sCMOS camera (Andor). Fusion was used as the acquisition software pro-
vided by Andor. Here, 561 nm (50% intensity) and 637 nm (80% intensity) laser
were used to acquire the images with the Nikon 100X/NA1.4 oil immersion
objective of the Nikon Eclipse TiE inverted microscope. The same parameters of
laser intensity and exposure time (500 ms) were used for all conditions across the
differentiation. The whole cell was acquired using a Piezo Z-stage (0.2 μm stack);
3D reconstituted images were deconvolved using Fusion deconvolution algorithm
to reassign out-of-focus light contribution to their initial location in the
source image.
Image processing. The 3D reconstituted images were analysed using IMARIS
software (Bitplane). The intensity of each signal was set with a different
threshold for each day of the differentiation but remained the same across
conditions. Surfaces were created for TOM20, ATP5a and ATG12 signals with a
smooth surface detail of 0.001, 0.05 and 0.05 μm, respectively. The threshold of
detection was adjusted manually to ensure the intensity detection made by the
software corresponds to the signal identified by eye. A filter was applied to
remove unspecific created surfaces below 0.5 µm for TOM20 and ATP5a signals.
The bottom half of cells was removed from the analysis and a filter was created
for ATG12 signal to remove the background. To identify and count the number
of replicating mtDNA molecules, a spot detection was created to detect the Alexa
647 intensity signal with similar parameters as the surfaces mentioned above.
Spots were assigned to an intensity signal with an estimated diameter of 0.6 μm.
The number of spots colocalizing with the mitochondria was calculated by
IMARIS using a ‘distance surface close to spot’ tool with a threshold of distance
equal to 0. Data were normalised to the same untreated control cell line
prepared and analysed in parallel on each day to account for the day-to-day
experimental variability. For polarisation analysis, a spot surface was generated
for TOM20 intensity. A reference point was placed at the centre of the cell in its
3D space allowing the division of each cell into 8 sections according to the x, y
and z axes. Spots present in each section were counted and divided by the total
number of count per cell (p_i). The polarity index was calculated as the entropy
of all 8 p_i.
sc-RNA-seq and gene expression analysis. Single cells were sorted by FACS into
the wells of a 96-well plate containing lysis buffer. Illumina Nextera XT DNA
preparation kit was used to prepare the libraries. Pooled libraries of 96 cells were
sequenced on a Hi-Seq 2500 (single-end 50 bp read length). Raw FASTQ files from
10x sequencing set were demultiplexed and aligned to the GRCm39 reference
genome using STARsolo56, with default settings set according to the 10x chromium
chemistry used. For the expression matrix analysis, we used Scanpy and performed
standard pre-processing steps: removing cells with less than 200 genes, removing
genes that have been detected in less than 3 cells, normalisation to 10,000 reads per
cell and log-transformation57. Wilcoxon rank-sum tests were used with significance
threshold of 0.05 for DEG discovery and use the Benjamini-Hochberg procedure to
obtain multiple-testing corrected p-values. To assign each cell an OXPHOS, gly-
colytic, autophagy and mtDNA replication scores, we count the number of genes
that are expressed in each cell, which are annotated within their respective gene list
(Supplementary Data 2) or with their respective GO term list (GO:0006096 for
‘glycolytic process’ and GO:0006119 for ‘oxidative phosphorylation’) and normalise
the score.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Raw sequencing data are available in the Gene Expression Omnibus under accession
number GSE169427. Raw data corresponding to the figures are included in
Supplementary Data 1, and heteroplasmy data are shown in Supplementary Data 3. Any
remaining information can be obtained from the corresponding author upon reasonable
request.
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